CFG
GSK icon

Carr Financial Group’s GSK GSK Stock Holding History

Carr Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,314
Closed -$702K – 185
2025
Q4 		$702K Buy
14,314
+139
+1% +$6.48K 0.19% 82
2025
Q3 		$612K Buy
14,175
+156
+1% +$6.09K 0.17% 92
2025
Q2 		$538K Buy
14,019
+164
+1% +$6.27K 0.16% 91
2025
Q1 		$537K Sell
13,855
-2,168
-14% -$79.4K 0.18% 86
2024
Q4 		$542K Buy
16,023
+75
+0.5% +$2.7K 0.17% 88
2024
Q3 		$652K Buy
15,948
+147
+0.9% +$6.01K 0.19% 90
2024
Q2 		$608K Sell
15,801
-213
-1% -$8.96K 0.19% 88
2024
Q1 		$687K Buy
16,014
+213
+1% +$8.78K 0.23% 73
2023
Q4 		$586K Hold
15,801
– – 0.22% 76
2023
Q3 		$544K Buy
15,801
+613
+4% +$21.8K 0.22% 82
2023
Q2 		$541K Buy
15,188
+504
+3% +$18.1K 0.22% 85
2023
Q1 		$527K Hold
14,684
– – 0.23% 80
2022
Q4 		$521K Buy
+14,684
New +$489K 0.27% 79

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Carr Financial Group's GSK Position: Q1 2026 in Review

Carr Financial Group sold out of GSK (GSK) in Q1 2026, closing a stake of 14,314 shares — an estimated $702K sold.

Carr Financial Group first reported a position in GSK in Q4 2022 and held it in 13 quarters. The position peaked at $702K in Q4 2025. 1,035 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Carr Financial Group reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • Carr Financial Group sold 14,314 GSK shares in Q1 2026, an estimated $702K.
  • Carr Financial Group first reported a position in GSK in Q4 2022 and held it in 13 quarters.
  • Carr Financial Group's GSK position peaked at $702K in Q4 2025.
  • 1,035 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Carr Financial Group's 13F filing for Q1 2026, filed 12 May 2026.